Syngene International beneficiary of the shift from Chemical drugs to biological drugs.
Syngene is one of India’s leading CRAMS organisations
Company has grown its revenue at 17.54% in past 5 years, while PAT grew at a CAGR of 8.73%
Shift from chemical drugs to biological drugs
Out of top 10 selling drugs in the world 8 are biologics.
Every year, around 2/3rd of the new business comes from existing clients and the rest from new clients.
Hyderabad which expanded further in Q4 FY23 ¤tly accommodates ~900 scientists.
during the year, the campus in Hyderabad added 400 scientists
Glasp is a social web highlighter that people can highlight and organize quotes and thoughts from the web, and access other like-minded people’s learning.